Clee Medical is proud to announce a strategic partnership with the Swiss Foundation for Innovation and Training in Surgery (SFITS) to accelerate the clinical validation and adoption of its real-time intraoperative imaging and AI-guided navigation technology.
This collaboration marks a significant milestone in Clee Medical’s mission to empower neurosurgeons with real-time visualization of brain anatomy and vasculature at unprecedented precision. By integrating ultra-high-resolution imaging with AI-based anatomical detection, the company’s Neuro Access platform aims to enhance surgical accuracy, improve patient safety, and expand access to advanced neurotherapies.
Working alongside SFITS, a leading European center for surgical training and innovation, the partnership will also enable early integration of Neuro Access into surgical training programs. This hands-on collaboration will foster direct feedback from clinicians and accelerate technology refinement under real-world conditions.
“Partnering with SFITS allows us to demonstrate and evolve our technology within one of the most advanced surgical innovation environments in Europe,
said Matthew Lapinski, CEO of Clee Medical.
It’s an important step toward bringing safer, more precise, and more effective neurosurgery to patients worldwide.
Dr. Jelena Godjevac, CEO of SFITS, added:
We are delighted to welcome Clee Medical to our ecosystem. Their real-time neuroimaging and navigation platform represents the kind of innovation that advances surgical excellence and patient outcomes.
This partnership reinforces Clee Medical’s commitment to bridging the gap between next-generation neurotechnology and clinical practice and is a significant step forward towards a new era of patient-centered innovation in neurosurgery.